Oncocyte Presents DetermaIO(TM) Data at ASCO 2022 Supporting the Test’s Potential to Expand the Clinical Use of Immunotherapy May 26, 2022
Qualigen Therapeutics’ Pan-RAS Inhibitor Featured in Two Abstracts at American Society for Clinical Oncology (ASCO) 2022 Annual Meeting May 26, 2022